Skip to content

Clinical trials

Hemorrhage trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Country / region: Netherlands Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20071
20092
20102
20112
20123
20131
20144
20151
20161
20184
20191
20207
20212
20223
20235
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Recruiting11
Unknown status3
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
St. Antonius Hospital7
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3
Radboud University Medical Center2
Takeda2
University Medical Center Groningen2
Abbott Medical Devices1
Alexion Pharmaceuticals, Inc.1
Amphia Hospital1
AstraZeneca1
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage44
Stroke6
Thrombosis6
Aortic Valve Stenosis5
Atrial Fibrillation4
Cardiovascular Diseases4
Embolism and Thrombosis4
Myocardial Infarction4
Heart Diseases3
Hemophilia A3

Trials

Showing 26 to 44 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.